Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Improved Outcomes in Paroxysmal Nocturnal Hemoglobinuria Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in 2011-2020: A Retrospective EBMT-Saawp Study

Blood (2024) 144 (Supplement 1): 305.

https://doi.org/10.1182/blood-2024-194716

Published: 2024

Journal Articles

Optimizing Haploidentical Transplant for Adults with Acute Lymphoblastic Leukemia: The Role of Donor and Graft Selection. a Study from the ALWP of the EBMT

Blood (2024) 144 (Supplement 1): 2193.

https://doi.org/10.1182/blood-2024-208242

Published: 2024

Journal Articles

Evaluating the Performance of Large Language Models in Hematopoietic Stem Cell Transplantation Decision Making

Ivan Civettini, Arianna Zappaterra, Daniele Ramazzotti, Bianca Maria Granelli, Giovanni Rindone, Andrea Aroldi, Stefano Bonfanti, Federica Colombo, Marilena Fedele, Giovanni Grillo, Matteo Parma, Paola Perfetti, Elisabetta Terruzzi, Carlo Gambacorti-Passerini, Fabrizio Cavalca

Blood (2023) 142 (Supplement 1): 3726.

https://doi.org/10.1182/blood-2023-185854

Published: 2023

Journal Articles

Autologous Peripheral Blood Stem Cell Mobilisation Techniques, Stem Cell Yields and Practice Variation-By-Country in Patients with Myeloma Undergoing First Autologous Stem Cell Transplants in EBMT Centres between 2012 and 2021

Blood (2022) 140 (Supplement 1): 10434–10436.

https://doi.org/10.1182/blood-2022-169736

Published: 2022

Journal Articles

CD24/Siglec-10 "Don't Eat Me" Signal Blockade Is a Potential Immunotherapeutic Target in Mantle-Cell Lymphoma

Andrea Aroldi, Mario Mauri, Matteo Parma, Elisabetta Terruzzi, Marilena Fedele, Paola Perfetti, Federica Cocito, Luca Mologni, Roberto Chiarle, Rocco Piazza, Carlo Gambacorti-Passerini

Blood (2021) 138 (Supplement 1): 2276.

https://doi.org/10.1182/blood-2021-154086

Published: 2021

Journal Articles

Feasibililty of Azacitidine As Bridge to Allogeneic Stem Cell Transplantation in Patients with Higher-Risk MDS or Low-Blast Count AML: Results of the BMT-AZA Multicenter Prospective Study

Blood (2015) 126 (23): 66.

https://doi.org/10.1182/blood.V126.23.66.66

Published: 2015

Journal Articles

Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients

Blood (2012) 120 (21): 743.

https://doi.org/10.1182/blood.V120.21.743.743

Published: 2012

Journal Articles

In vitro and in vivo model of a novel immunotherapy approach for chronic lymphocytic leukemia by anti-CD23 chimeric antigen receptor

Greta Maria Paola Giordano Attianese, Virna Marin, Valentina Hoyos, Barbara Savoldo, Irene Pizzitola, Sarah Tettamanti, Valentina Agostoni, Matteo Parma, Maurilio Ponzoni, Maria T. S. Bertilaccio, Paolo Ghia, Andrea Biondi, Gianpietro Dotti, Ettore Biagi

Blood (2011) 117 (18): 4736–4745.

https://doi.org/10.1182/blood-2010-10-311845

Published: 2011

Includes: Supplemental data

Journal Articles

A New Chimeric Antigen Receptor (CAR) Targeting the CD23 Antigen Expressed by Chronic Lymphocytic Leukemia (B-CLL) Cells

Greta Maria Paola Giordano Attianese, PhD, Valentina Hoyos, MD, Virna Marin, PhD, Barbara Savoldo, Irene Pizzitola, PhD, Valentina Agostoni, PhD, Matteo Parma, MD, Maria Teresa Sabrina Bertilaccio, PhD, Paolo Ghia, Andrea Biondi, MD, Gianpietro Dotti, Ettore Biagi, MD, PhD

Blood (2010) 116 (21): 2446.

https://doi.org/10.1182/blood.V116.21.2446.2446

Published: 2010

Journal Articles

Nonmyeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo

Blood (2009) 113 (14): 3375–3382.

https://doi.org/10.1182/blood-2008-07-167379

Published: 2009

Journal Articles

Chimerism Status Analysis after Hematopoietic Stem CellTransplantation on Granulocytes and Mononucleated Cells of Peripheral Blood

Matteo Parma, MD, Elisa Doni, MD, Federica Colnaghi, PhD, Arianna Colombo, PhD, Elena Elli, MD, Pietro Pioltelli, MD, Elisabetta Terruzzi, MD, Enrico Maria Pogliani, MD

Blood (2008) 112 (11): 4604.

https://doi.org/10.1182/blood.V112.11.4604.4604

Published: 2008

Journal Articles

Impact of JAK2V617F Mutational Status on Clinical and Laboratory Phenotype at Diagnosis and during Follow-up in Patients with Essential Thrombocythemia

Elena Elli, MD, Angelo Belotti, MD, Matteo Parma, MD, Federica Colnaghi, PhD, Arianna Colombo, PhD, Eraldo Lanzi, MD, Pietro Pioltelli, MD, Enrico Maria Pogliani, MD

Blood (2008) 112 (11): 5256.

https://doi.org/10.1182/blood.V112.11.5256.5256

Published: 2008

Journal Articles

Interleukin-17-Producing T Cells: A New Potential Player Mediating Graft Versus Host Pathology In Patients Undergoing Allogeneic Stem Cell Transplantion

Erica Dander, Adriana Balduzzi, Greta Zappa, Paolo Perseghin, Giovanna Lucchini, Elisabetta Todisco, Matteo Parma, Ettore Biagi, Iolanda Di Biasio, Antonello Villa, Pamela Della Mina, Maddalena Migliavacca, Daniela Longoni, Attilio Rovelli, Andrea Biondi, Giovanna D’Amico

Blood (2008) 112 (11): 1250.

https://doi.org/10.1182/blood.V112.11.1250.1250

Published: 2008

Journal Articles

Early and Late Complications in 247 Adult Autologous Stem Cell Transplant Recipients.

Elisabetta Terruzzi, Chiara Scollo, Fausto Rossini, Matteo Parma, Pietro Pioltelli, Enrico Maria Pogliani

Blood (2006) 108 (11): 5242.

https://doi.org/10.1182/blood.V108.11.5242.5242

Published: 2006

Journal Articles

Infusion of Donor Derived Cytokine Induced Killer Cells May Induce Clinical Remission with Limited GVHD in Patients Relapsing after Allogeneic Stem Cell Transplantation.

Martino Introna, MD, Gianmaria Borleri, Elena Conti, Anna M. Barbui, MD, Raewyn Broady, BSc, Erica Dander, BSc, Giuseppe Gaipa, BSc, Giovanna D’Amico, BSc, Ettore Biagi, MD, Matteo Parma, MD, Enrico Pogliani, MD, Orietta Spinelli, BSc, Donatella Baronciani, MD, Anna Grassi, MD, Josee Golay, PhD, Tiziano Barbui, MD, Andrea Biondi, MD, Alessandro Rambaldi, MD

Blood (2006) 108 (11): 3698.

https://doi.org/10.1182/blood.V108.11.3698.3698

Published: 2006

NARROW

Improved Outcomes in Paroxysmal Nocturnal Hemoglobinuria Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in 2011-2020: A Retrospective EBMT-Saawp Study

Optimizing Haploidentical Transplant for Adults with Acute Lymphoblastic Leukemia: The Role of Donor and Graft Selection. a Study from the ALWP of the EBMT

Evaluating the Performance of Large Language Models in Hematopoietic Stem Cell Transplantation Decision Making

Autologous Peripheral Blood Stem Cell Mobilisation Techniques, Stem Cell Yields and Practice Variation-By-Country in Patients with Myeloma Undergoing First Autologous Stem Cell Transplants in EBMT Centres between 2012 and 2021

CD24/Siglec-10 "Don't Eat Me" Signal Blockade Is a Potential Immunotherapeutic Target in Mantle-Cell Lymphoma

Feasibililty of Azacitidine As Bridge to Allogeneic Stem Cell Transplantation in Patients with Higher-Risk MDS or Low-Blast Count AML: Results of the BMT-AZA Multicenter Prospective Study

Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients

In vitro and in vivo model of a novel immunotherapy approach for chronic lymphocytic leukemia by anti-CD23 chimeric antigen receptor

A New Chimeric Antigen Receptor (CAR) Targeting the CD23 Antigen Expressed by Chronic Lymphocytic Leukemia (B-CLL) Cells

Nonmyeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo

Chimerism Status Analysis after Hematopoietic Stem CellTransplantation on Granulocytes and Mononucleated Cells of Peripheral Blood

Impact of JAK2V617F Mutational Status on Clinical and Laboratory Phenotype at Diagnosis and during Follow-up in Patients with Essential Thrombocythemia

Interleukin-17-Producing T Cells: A New Potential Player Mediating Graft Versus Host Pathology In Patients Undergoing Allogeneic Stem Cell Transplantion

Early and Late Complications in 247 Adult Autologous Stem Cell Transplant Recipients.

Infusion of Donor Derived Cytokine Induced Killer Cells May Induce Clinical Remission with Limited GVHD in Patients Relapsing after Allogeneic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only